Neuberger Berman Group LLC Immunovant, Inc. Transaction History

Neuberger Berman Group LLC

  • $123 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Nov 14, 2024
BUY
$31.31 - $44.19 $1.37 Million - $1.93 Million
43,720 New
43,720 $1.84 Million
Q4 2023

Feb 09, 2024
SELL
$31.31 - $44.19 $253,673 - $358,027
-8,102 Reduced 15.63%
43,720 $1.84 Million
Q3 2023

Nov 14, 2023
SELL
$18.55 - $39.96 $481,650 - $1.04 Million
-25,965 Reduced 33.38%
51,822 $1.99 Million
Q2 2023

Aug 11, 2023
BUY
$14.2 - $23.75 $1.1 Million - $1.85 Million
77,787 New
77,787 $1.48 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email